FeesSafety
Pluang+

Nordicus Partners uplists to Nasdaq Capital Market, boosting visibility for its biotech innovations.

Company Fundamentals
29 Oct 2026, 23:05 WIB
GlobeNewsWire
View Source
Bullish
Nordicus Partners uplists to Nasdaq Capital Market, boosting visibility for its biotech innovations.

Nordicus Partners Corporation, a biotech firm focused on developing treatments for oral disorders and other unmet medical needs, announced its shares will begin trading on the Nasdaq Capital Market starting October 30, 2026. This uplisting enhances the company's visibility and access to capital markets, supporting its growth and drug development efforts. Nordicus recently acquired two Danish biotech companies to advance therapies for periodontitis and oral leukoplakia. Shareholders do not need to take any action for this transition.

Nordicus Partners Corporation uplisting to Nasdaq Capital Market is the story's subject. For readers following the health sector, here is Pluang's market snapshot as of Oct 30, 2026 03:11 WIB: Out of 150 priced US health stocks, 106 rose and 44 fell. Notable movers include CTXR at USD 0.60 with a 1-day change of +10.64% and 100% sell order activity, WGS at USD 71.25 with +10.14% and 100% buy order activity, and BAX at USD 23.43 with -7.97% change and a typical hold time of 72 days.

More News

iHerb adds eBay's Jordan Sweetnam to board to boost global eCommerce growth and customer experience.

iHerb adds eBay's Jordan Sweetnam to board to boost global eCommerce growth and customer experience.

iHerb Holdings appointed Jordan Sweetnam, eBay's Chief Commercial Officer, as an independent director to its board. Sweetnam brings extensive experience in global eCommerce, having held senior roles at eBay and Walmart, and will support iHerb's expan...

Company Fundamentals
Bullish
3 hours ago
Alnylam Pharmaceuticals shares drop over 28% after lowering 2026 sales guidance, prompting fraud investigation.

Alnylam Pharmaceuticals shares drop over 28% after lowering 2026 sales guidance, prompting fraud investigation.

Alnylam Pharmaceuticals announced on July 30, 2026, that it lowered its full-year 2026 sales guidance for its TTR product by about $200 million due to slower than expected market growth. This caused the stock to fall 28.31%, injuring investors. On Oc...

Market News
Bearish
4 hours ago
Hyperliquid (HYPE) token rises 3% in an hour, gains 17.28% in 24 hours amid heavy liquidations.

Hyperliquid (HYPE) token rises 3% in an hour, gains 17.28% in 24 hours amid heavy liquidations.

Hyperliquid (HYPE) token price increased by 3.00% within one hour on October 29, reaching $94.82 on Binance. Over the same 24-hour period, HYPE gained 17.28%, reflecting strong upward momentum. During this hour, significant liquidations occurred with...

Market News
Bullish
4 hours ago
Harley-Davidson seen overvalued at 27x P/E with weak earnings and limited growth outlook through 2027.

Harley-Davidson seen overvalued at 27x P/E with weak earnings and limited growth outlook through 2027.

Harley-Davidson is currently trading at a high valuation of 27 times its earnings despite weak operating income and declining sales forecasts projected through 2027. Recent improvements in retail and inventory have not translated into sustainable ear...

Analyst Insights
Bearish
4 hours ago
$5.57B stolen from Binance-linked wallets in possible record crypto hack; investigation ongoing.

$5.57B stolen from Binance-linked wallets in possible record crypto hack; investigation ongoing.

At least $5.57 billion in cryptocurrency was moved out of Binance-linked wallets across Ethereum, Bitcoin, and Tron blockchains in what appears to be a major security breach. Binance has not confirmed a hack but is actively investigating the potentia...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App